胎盘植入谱系疾病的保守管理或剖宫产子宫切除术:PACCRETA前瞻性研究
在176家医院520,114次分娩中前瞻性纳入胎盘植入谱系疾病孕妇,比较剖宫产子宫切除术与保守管理(胎盘原位保留)的严重母体结局。主要结局为产后6个月内输注>4单位浓缩红细胞,保守管理组14/86例(16.3%)vs 剖宫产子宫切除术组36/61例(59.0%),倾向评分加权模型风险比0.29(95%CI 0.19-0.45)。
要点
- 保守管理组产后6个月内输注>4单位浓缩红细胞的比例为16.3%,剖宫产子宫切除术组为59.0%。
- 倾向评分加权模型风险比0.29(95%CI 0.19-0.45),保守管理组输血风险更低。
- 保守管理组子宫切除术、总估计失血量>3000mL、任何血制品输注、邻近器官损伤及非产后出血相关严重母体并发症发生率更低(均校正后P≤.02)。
核心结论
- 在剖宫产分娩的胎盘植入谱系疾病孕妇中,保守管理与剖宫产子宫切除术相比,产后6个月内输注>4单位浓缩红细胞的风险更低。
研究设计与样本
- 研究为观察性队列,源人群为176家医院520,114次分娩(PACCRETA研究),纳入剖宫产分娩时行剖宫产子宫切除术或保守管理(胎盘原位保留)的胎盘植入谱系疾病孕妇。
- 临床医生前瞻性识别符合纳入标准的孕妇并于分娩时纳入,数据收集在孕妇产后即刻获得信息并同意参与后开始。
- 共86例接受保守管理,62例接受剖宫产子宫切除术。
- 采用倾向评分加权校正潜在指征偏倚。
主要发现
- 主要结局(产后6个月内输注>4单位浓缩红细胞)在保守管理组86例中发生14例(16.3%),在剖宫产子宫切除术组61例中发生36例(59.0%),倾向评分加权模型风险比0.29(95%CI 0.19-0.45)。
- 保守管理组子宫切除术、总估计失血量>3000mL、任何血制品输注、邻近器官损伤及非产后出血相关严重母体并发症发生率均低于剖宫产子宫切除术组(均校正后P≤.02)。
- 保守管理组动脉栓塞、子宫内膜炎及出院后6个月内再入院发生率高于剖宫产子宫切除术组。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Placenta accreta spectrum is a life-threatening condition that has increased dramatically in recent decades along with cesarean rates worldwide. Cesarean hysterectomy is widely practiced in women with placenta accreta spectrum; however, the maternal outcomes after cesarean hysterectomy have not been thoroughly compared with the maternal outcomes after alternative approaches, such as conservative management. OBJECTIVE: This study aimed to compare the severe maternal outcomes between women with placenta accreta spectrum treated with cesarean hysterectomy and those treated with conservative management (leaving the placenta in situ). STUDY DESIGN: From a source population of 520,114 deliveries in 176 hospitals (PACCRETA study), we designed an observational cohort of women with placenta accreta spectrum who had either a cesarean hysterectomy or a conservative management (the placenta left in situ) during cesarean delivery. Clinicians prospectively identified women meeting the inclusion criteria and included them at delivery. Data collection started only after the women had received information and agreed to participate in the study in the immediate postpartum period. The primary outcome was the transfusion of >4 units of packed red blood cells within 6 months after delivery. Secondary outcomes were other maternal complications within 6 months. We used propensity score weighting to account for potential indication bias. RESULTS: Here, 86 women had conservative management and 62 women had cesarean hysterectomy for placenta accreta spectrum during cesarean delivery. The primary outcome occurred in 14 of 86 women in the conservative management group (16.3%) and 36 of 61 (59.0%) in the cesarean hysterectomy group (risk ratio in propensity score weighted model, 0.29; 95% confidence interval, 0.19-0.45). The rates of hysterectomy, total estimated blood loss exceeding 3000 mL, any blood product transfusion, adjacent organ injury, and nonpostpartum hemorrhage-related severe maternal morbidity were lower with conservative management than with cesarean hysterectomy (all adjusted, P≤.02); but, the rates of arterial embolization, endometritis, and readmission within 6 months of discharge were higher with conservative management than with cesarean hysterectomy. CONCLUSION: Among women with placenta accreta spectrum who underwent cesarean delivery, conservative management was associated with a lower risk of transfusion of >4 units of packed red blood cells within 6 months than cesarean hysterectomy.
引用
- Sentilhes L, Seco A, Azria E, et al. Conservative management or cesarean hysterectomy for placenta accreta spectrum: the PACCRETA prospective study. Am J Obstet Gynecol. 2021. PMID: 34914894. doi:10.1016/j.ajog.2021.12.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。